Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome Prospective Open-Label Antiplatelet Study - TRANSLATE-POPS


Current guidelines list platelet testing as a Class IIb indication in select patients with unstable angina/non–ST-segment elevation myocardial infarction (NSTEMI) if testing would change clinical management. To date, however, randomized clinical trials have failed to demonstrate that altering adenosine diphosphate (ADP) therapy in response to platelet function testing improves patient outcomes.

The current trial sought to study if access to platelet testing in routine clinical ...